Article
Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.
PloS one - 1 Jan 2018
Figueroa Dominique B, Tillotson Joseph, Li Maoji, Piwowar-Manning Estelle, Hendrix Craig W, Holtz Timothy H, Bokoch Kevin, Bekker Linda-Gail, van Griensven Frits, Mannheimer Sharon, Hughes James P, Grant Robert M, Bumpus Namandjé N
Abstract excerpt
Tenofovir (TFV), a nucleotide reverse transcriptase inhibitor, requires two phosphorylation steps to form a competitive inhibitor of HIV reverse transcriptase. Adenylate kinase 2 (AK2) has been previously demonstrated to phosphorylate tenofovir to tenofovir-monophosphate, while creatine kinase, muscle (CKM), pyruvate kinase, muscle (PKM) and pyruvate kinase, liver and red blood cell (PKLR) each have been found to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
